搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
新京报 on MSN
42 分钟
北海康成一款戈谢病新药拟纳入优先审评
新京报讯(记者张兆慧)9月20日,家药监局药品审评中心官网公示,北海康成注射用维拉苷酶β拟纳入优先审评,适用于确诊为戈谢病I型(GD1)和Ⅲ型(GD3)患者的长期酶替代治疗(ERT)。注射用维拉苷酶β是北海康成针对戈谢病开发的酶替代疗法CAN103。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Alabama mass shooting
On running again in 2028
Daylight saving time
No govt. shutdown for now
Free COVID-19 tests
California plastic bag ban
Dolphins legend Morris dies
San Francisco homelessness
CA firefighter held for arson
Released after guilty plea
Donlon's homes searched
Ga. suspect's mom indicted
No. 1 at box office again
PM Modi visits US
TN abortion law blocked
Hezbollah rockets hit Israel
J&J unit files for bankruptcy
SC 1st execution in 13 years
CA bill to protect kids online
ISR raids Al Jazeera office
Sesame Place suit verdict
Former WA governor dies
Suns broadcaster dies
Iran coal mine blast
Robinson loses key staff
Biden hosts 'Quad' summit
CAH sues for trespassing
FDA approves flu vaccine
Boeing defense chief exits
Pandas leaving for China
Drug price challenge revived
反馈